6505--Rituximab Biosimilars (VA-20-00048624)
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79720R0045
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This pre-solicitation notice is for a request for proposal to provide rituximab to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The VA intends to award a one-year contract with four one-year option periods to the responsible offeror who can provide an uninterrupted supply of an estimated 21,788 vials of 100mg rituximab and 26,793 vials of 500mg rituximab annually. Solicitation number 36E79720R0045 will be issued electronically on May 28, 2020 in a commercial item format according to FAR Part 12, with a closing date for proposals of June 11, 2020.
There is no set-aside designated for this procurement. The NAICS code is 325412, pharmaceutical preparation manufacturing. Interested parties should monitor the FedBizOpps website for any amendments as the point of contact is Kenneth Lay. Offerors must be able to supply the exact drug name and have a unique NDC number. The estimated annual quantities are provided above and the total value will depend on the offerors' pricing over the potential five-year ordering period.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0045 for an unrestrictive procurement for RITUXIMAB, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0045 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 28, 2020, with a tentative closing date of June 11, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Kenneth Lay Questions can be e-mailed to: Kenneth.Lay@va.gov.
The estimated annual requirements are as follows:
Item
Description
Package Size (Vials)
Total Estimated Annual Usage (Vials)
1a
RITUXIMAB 100MG
OR
2a
RITUXIMAB-ABBS 100MG
1
21,788
OR
3a
RITUXIMAB-PVVR 100MG
1b
RITUXAN 500MG
OR
2b
RITUXIMAB-ABBS 500MG
1
26,793
OR
3b
RITUXIMAB-PVVR 500MG
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79720R0045-000.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Rituximab Biosimilars (VA-20-00048624) Effective 9/15/2020-09/14/2021 | Award Notice | |
| 6505--Rituximab Biosimilars (VA-20-00048624) | Solicitation | |
| 6505--Rituximab Biosimilars (VA-20-00048624) | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity